Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.

In order to clarify the diurnal pattern of secretion of plasma immunoreactive (IR) proopiomelanocortin (POMC)-derived peptides, IR-N-terminal peptide (Nt), IR-beta-endorphin (Ep), IR-beta-lipotropin (LPH), and IR-ACTH (ACTH) in normal subjects and in patients with Addison's disease and Cushing's disease, we measured these 4 peptides in the same plasma obtained at 0900 h and then every three hours until 0600 h at the next day. All four peptides showed diurnal rhythms with the peaks at 0600 h, and the nadirs of ACTH, LPH, Ep and Nt were at 0000 h, 0000 h, 1800 h and 0300, respectively in normal subjects. In patients with Addison's disease, these four peptides also showed diurnal rhythms with the peaks at 0600 h for ACTH and Ep and at 0900 h for LPH and Nt, and the nadirs at 2100 h for ACTH and Ep and at 0000 h for LPH and Nt. The molar ratios of Ep/ACTH, LPH/ACTH and Nt/ACTH in plasma also presented diurnal variations in normal subjects and in patients with Addison's disease. On the other hand, in patients with Cushing's disease, ACTH, LPH and Nt showed no rhythmicity or change in molar ratios of Ep/ACTH, LPH/ACTH or Nt/ACTH. Only Ep showed diurnal variation. The molar ratios of Ep/ACTH, LPH/ACTH and Nt/ACTH in patients with Cushing's disease were significantly higher than those in normal subjects and in patients with Addison's disease at 0000 h.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  G. Chrousos,et al.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications. , 1985, The Journal of clinical investigation.

[2]  H. Ibayashi,et al.  Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation. , 1984, The Journal of clinical endocrinology and metabolism.

[3]  F. Petraglia,et al.  Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. , 1983, Hormone research.

[4]  J. Sowers,et al.  DOPAMINE REGULATES CANINE PLASMA β-ENDORPHIN-IMMUNOREACTIVITY LEVELS , 1982 .

[5]  W. Nicholson,et al.  Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. , 1982, Endocrinology.

[6]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[7]  C. Guilleminault,et al.  Diurnal rhythm of plasma immunoreactive beta-endorphin and its relationship to sleep stages and plasma rhythms of cortisol and prolactin. , 1981, The Journal of clinical endocrinology and metabolism.

[8]  N. Kalin,et al.  Episodic secretion of opioid activity in human plasma and monkey CSF: evidence for a diurnal rhythm. , 1981, Life sciences.

[9]  I. Vermes,et al.  Differential control of β-endorphin/β-lipotropin secretion from anterior and intermediate lobes of the rat pituitary gland in vitro , 1980 .

[10]  P. Mullen,et al.  THE CIRCADIAN VARIATION OF IMMUNOREACTIVE LIPOTROPHIN AND ITS RELATIONSHIP TO ACTH AND GROWTH HORMONE IN MAN , 1979, Clinical endocrinology.

[11]  D. Krieger,et al.  Human plasma immunoreactive lipotropin and adrenocorticotropin in normal subjects and in patients with pituitary-adrenal disease. , 1979, The Journal of clinical endocrinology and metabolism.

[12]  R. Przewłocki,et al.  beta-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates. , 1978, Life sciences.

[13]  W. Nicholson,et al.  Diurnal rhythm and disappearance half-time of endogenous plasma immunoreactive beta-MSH (LPH) and ACTH in man. , 1978, The Journal of clinical endocrinology and metabolism.

[14]  T F Gallagher,et al.  ACTH and cortisol secretory patterns in man. , 1973, The Journal of clinical endocrinology and metabolism.

[15]  X. Bertagna,et al.  Simultaneous Assay of Immunoreactive β-Lipotropin, γ-Lipotropin, and β-Endorphin in Plasma of Normal Human Subjects, Patients with ACTH/Lipotropin Hypersecretory Syndromes, and Patients undergoing Chronic Hemodialysis , 1981 .